178 related articles for article (PubMed ID: 37332023)
1. Skeletal muscle alterations indicate poor prognosis in cirrhotic patients: a multicenter cohort study in China.
Zeng X; Shi ZW; Yu JJ; Wang LF; Sun CY; Luo YY; Shi PM; Lin Y; Chen YX; Guo J; Zhang CQ; Xie WF
Hepatol Int; 2024 Apr; 18(2):673-687. PubMed ID: 37332023
[TBL] [Abstract][Full Text] [Related]
2. Sarcopenia as a prognostic predictor of liver cirrhosis: a multicentre study in China.
Zeng X; Shi ZW; Yu JJ; Wang LF; Luo YY; Jin SM; Zhang LY; Tan W; Shi PM; Yu H; Zhang CQ; Xie WF
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1948-1958. PubMed ID: 34520115
[TBL] [Abstract][Full Text] [Related]
3. Albumin-myosteatosis gauge as a novel prognostic risk factor in patients with non-metastatic colorectal cancer.
Kim Y; Lee JH; Cho ES; Lee HS; Shin SJ; Park EJ; Baik SH; Lee KY; Kang J
J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):860-868. PubMed ID: 36696881
[TBL] [Abstract][Full Text] [Related]
4. A dynamic association between myosteatosis and liver stiffness: Results from a prospective interventional study in obese patients.
Nachit M; Lanthier N; Rodriguez J; Neyrinck AM; Cani PD; Bindels LB; Hiel S; Pachikian BD; Trefois P; Thissen JP; Delzenne NM
JHEP Rep; 2021 Aug; 3(4):100323. PubMed ID: 34355155
[TBL] [Abstract][Full Text] [Related]
5. Albumin-myosteatosis gauge as a prognostic factor in patients with advanced pancreatic cancer undergoing first-line chemotherapy.
Sahin TK; Ozbay Y; Altunbulak AY; Altunbulak HI; Onur MR; Ceylan F; Guven DC; Yalcin S; Dizdar O
Int J Clin Oncol; 2024 Jun; 29(6):822-831. PubMed ID: 38565751
[TBL] [Abstract][Full Text] [Related]
6. Impact of low skeletal muscle mass and quality on clinical outcomes in patients with head and neck cancer undergoing (chemo)radiation.
Bardoscia L; Besutti G; Pellegrini M; Pagano M; Bonelli C; Bonelli E; Braglia L; Cozzi S; Roncali M; Iotti C; Pinto C; Pattacini P; Ciammella P
Front Nutr; 2022; 9():994499. PubMed ID: 36466387
[TBL] [Abstract][Full Text] [Related]
7. Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis.
Bhanji RA; Moctezuma-Velazquez C; Duarte-Rojo A; Ebadi M; Ghosh S; Rose C; Montano-Loza AJ
Hepatol Int; 2018 Jul; 12(4):377-386. PubMed ID: 29881992
[TBL] [Abstract][Full Text] [Related]
8. Meld-sarcopenia score and skeletal muscle density predicts short-term readmission of patients with hepatic encephalopathy.
Yang S; Zhang L; Jin Q; Wang J; Ma D; Gao J; Huang R
Eur J Radiol; 2023 Dec; 169():111178. PubMed ID: 37922620
[TBL] [Abstract][Full Text] [Related]
9. Myosteatosis for Early Detection of Muscle Disorder in Patients With Liver Cirrhosis.
Godbole S; Juveria S; Jagtap N; Kulkarni A; Lanka P; Sheikh S; Rao PN; Arulta M; Tr S; Shah S; Reddy DN; Sharma M
J Clin Exp Hepatol; 2024; 14(2):101312. PubMed ID: 38274507
[TBL] [Abstract][Full Text] [Related]
10. Skeletal Muscle Pathological Fat Infiltration (Myosteatosis) Is Associated with Higher Mortality in Patients with Cirrhosis.
Ebadi M; Tsien C; Bhanji RA; Dunichand-Hoedl AR; Rider E; Motamedrad M; Mazurak VC; Baracos V; Montano-Loza AJ
Cells; 2022 Apr; 11(8):. PubMed ID: 35456024
[TBL] [Abstract][Full Text] [Related]
11. Myosteatosis Is Not Associated with Complications or Survival in HCC Patients Undergoing Trans Arterial Embolization.
Masetti C; Pugliese N; Lofino L; Colapietro F; Ceriani R; Lleo A; Poretti D; Pedicini V; De Nicola S; Torzilli G; Rimassa L; Aghemo A; Lanza E
J Clin Med; 2022 Dec; 12(1):. PubMed ID: 36615062
[TBL] [Abstract][Full Text] [Related]
12. Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma.
Chen BB; Liang PC; Shih TT; Liu TH; Shen YC; Lu LC; Lin ZZ; Hsu C; Hsu CH; Cheng AL; Shao YY
Eur Radiol; 2023 Jan; 33(1):512-522. PubMed ID: 35864351
[TBL] [Abstract][Full Text] [Related]
13. Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis.
Montano-Loza AJ; Angulo P; Meza-Junco J; Prado CM; Sawyer MB; Beaumont C; Esfandiari N; Ma M; Baracos VE
J Cachexia Sarcopenia Muscle; 2016 May; 7(2):126-35. PubMed ID: 27493866
[TBL] [Abstract][Full Text] [Related]
14. Contributory roles of sarcopenia and myosteatosis in development of overt hepatic encephalopathy and mortality after transjugular intrahepatic portosystemic shunt.
Yin L; Chu SL; Lv WF; Zhou CZ; Liu KC; Zhu YJ; Zhang WY; Wang CX; Zhang YH; Lu D; Cheng DL
World J Gastroenterol; 2023 May; 29(18):2875-2887. PubMed ID: 37274064
[TBL] [Abstract][Full Text] [Related]
15. Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis.
Di Cola S; D'Amico G; Caraceni P; Schepis F; Loredana S; Lampertico P; Toniutto P; Martini S; Maimone S; Colecchia A; Svegliati Barone G; Alessandria C; Aghemo A; Crocè SL; Adinolfi LE; Rendina M; Lapenna L; Pompili E; Zaccherini G; Saltini D; Iavarone M; Tosetti G; Martelletti C; Nassisi V; Ferrarese A; Giovo I; Masetti C; Pugliese N; Campigotto M; Nevola R; Merli M;
J Hepatol; 2024 May; ():. PubMed ID: 38782120
[TBL] [Abstract][Full Text] [Related]
16. Impact of preoperative sarcopenia and myosteatosis on prognosis after radical cystectomy in patients with bladder cancer.
Yamashita S; Iguchi T; Koike H; Wakamiya T; Kikkawa K; Kohjimoto Y; Hara I
Int J Urol; 2021 Jul; 28(7):757-762. PubMed ID: 33821510
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of Sarcopenia and Myosteatosis in Patients with Resectable Pancreatic Ductal Adenocarcinoma.
Kim DW; Ahn H; Kim KW; Lee SS; Kim HJ; Ko Y; Park T; Lee J
Korean J Radiol; 2022 Nov; 23(11):1055-1066. PubMed ID: 36098341
[TBL] [Abstract][Full Text] [Related]
18. Assessment of muscle mass using chest computed tomography-based quantitative and qualitative measurements in patients with systemic sclerosis: A retrospective study with cross-sectional and longitudinal analyses.
da Rocha DS; Tessari JA; Mainardi NB; Hax V; Gasparin AA; de Oliveira CAV; Garcia TS; Xavier RM; Chakr RMDS
Semin Arthritis Rheum; 2023 Apr; 59():152168. PubMed ID: 36736023
[TBL] [Abstract][Full Text] [Related]
19. Association of myosteatosis with treatment response and survival in patients with hepatocellular carcinoma undergoing chemoembolization: a retrospective cohort study.
Bannangkoon K; Hongsakul K; Tubtawee T; Ina N; Chichareon P
Sci Rep; 2023 Mar; 13(1):3978. PubMed ID: 36894658
[TBL] [Abstract][Full Text] [Related]
20. The Presence of Myosteatosis Is Associated with Age, Severity of Liver Disease and Poor Outcome and May Represent a Prodromal Phase of Sarcopenia in Patients with Liver Cirrhosis.
Geladari E; Alexopoulos T; Kontogianni MD; Vasilieva L; Mani I; Tenta R; Sevastianos V; Vlachogiannakos I; Alexopoulou A
J Clin Med; 2023 May; 12(9):. PubMed ID: 37176772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
